HeartSciences Inc. Cash Flow-to-Debt Ratio
HeartSciences Inc. cash flow-to-debt ratio. HeartSciences Inc. (HSCS) has a Cash Flow-to-Debt Ratio of -228.56x as of July 2026, meaning its operating cash flow of $-1.32 Billion could theoretically repay -229% of its total liabilities ($5.77 Million) in one year. See HSCS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HeartSciences Inc. (2020–2026)
Cash flow-to-debt ratio of HeartSciences Inc. from 2020 to 2026. Historical debt coverage capacity for HeartSciences Inc. across 7 annual periods. Also explore HeartSciences Inc. annual equity growth to track the company's year-over-year net asset growth rate.
HeartSciences Inc. Cash Flow-to-Debt Ratio by Year (2020–2026)
HeartSciences Inc. cash flow-to-debt ratio by year from 2020 to 2026. Year-by-year debt coverage analysis for HeartSciences Inc.. For the full cash flow conversion analysis, see cash flow conversion of HeartSciences Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.00x | $-7.43 Million | $5.04 Billion | ▲ +99.9% |
| 2025 | -1.85x | $-7.41 Million | $4.02 Million | ▲ +33.6% |
| 2024 | -2.78x | $-6.07 Million | $2.19 Million | ▼ -47.0% |
| 2023 | -1.89x | $-5.77 Million | $3.06 Million | ▼ -322.2% |
| 2022 | -0.45x | $-3.64 Million | $8.15 Million | ▲ +30.0% |
| 2021 | -0.64x | $-2.45 Million | $3.84 Million | ▲ +72.7% |
| 2020 | -2.34x | $-3.84 Million | $1.64 Million | — |